Cyxone AB - ESG Rating & Company Profile powered by AI
The assessment of Cyxone AB was assembled by All Street Sevva using proprietary machine learning. Scroll down to the end of this page for potential risks for Cyxone AB based on industry, location and size. The assessment of Cyxone AB employs intelligence from across the internet and also from public documents by Cyxone AB.
Cyxone AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 4.0, social score of 8.0 and governance score of 2.7.
4.9
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
744 | Sopharma AD | 5.0 | High |
744 | vTv Therapeutics Inc | 5.0 | High |
764 | Cyxone AB | 4.9 | High |
764 | BetterLife Pharma Inc | 4.9 | High |
764 | Acerus Pharmaceuticals Corporation | 4.9 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Cyxone AB have an accelerator or VC vehicle to help deliver innovation?
Does Cyxone AB disclose current and historical energy intensity?
Does Cyxone AB report the average age of the workforce?
Does Cyxone AB reference operational or capital allocation in relation to climate change?
Does Cyxone AB disclose its ethnicity pay gap?
Does Cyxone AB disclose cybersecurity risks?
Does Cyxone AB offer flexible work?
Does Cyxone AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Cyxone AB disclose the number of employees in R&D functions?
Does Cyxone AB conduct supply chain audits?
Does Cyxone AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Cyxone AB conduct 360 degree staff reviews?
Does Cyxone AB disclose the individual responsible for D&I?
Does Cyxone AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Cyxone AB disclose current and / or historical scope 2 emissions?
Does Cyxone AB disclose water use targets?
Does Cyxone AB have careers partnerships with academic institutions?
Did Cyxone AB have a product recall in the last two years?
Does Cyxone AB disclose incidents of discrimination?
Does Cyxone AB allow for Work Councils/Collective Agreements to be formed?
Has Cyxone AB issued a profit warning in the past 24 months?
Does Cyxone AB disclose parental leave metrics?
Does Cyxone AB disclose climate scenario or pathway analysis?
Does Cyxone AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Cyxone AB disclose the pay ratio of women to men?
Does Cyxone AB support suppliers with sustainability related research and development?
Does Cyxone AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Cyxone AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Cyxone AB involved in embryonic stem cell research?
Does Cyxone AB disclose GHG and Air Emissions intensity?
Does Cyxone AB disclose its waste policy?
Does Cyxone AB report according to TCFD requirements?
Does Cyxone AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Cyxone AB disclose energy use targets?
Does Cyxone AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Cyxone AB have a policy relating to cyber security?
Have a different question?
Potential Risks for Cyxone AB
These potential risks are based on the size, segment and geographies of the company.
Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.